Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ReShape Lifesciences Inc. (RSLS)

3.08   -0.06 (-1.91%) 03-24 16:00
Open: 3.11 Pre. Close: 3.14
High: 3.29 Low: 3
Volume: 49,774 Market Cap: 6(M)

Technical analysis

as of: 2023-03-24 4:29:28 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.08     One year: 6.42
Support: Support1: 2.49    Support2: 2.07
Resistance: Resistance1: 4.35    Resistance2: 5.5
Pivot: 3.21
Moving Average: MA(5): 3.05     MA(20): 3.49
MA(100): 7.23     MA(250): 20.79
MACD: MACD(12,26): -0.7     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 29.2     %D(3): 27.6
RSI: RSI(14): 40.6
52-week: High: 68.5  Low: 0.56
Average Vol(K): 3-Month: 881 (K)  10-Days: 283 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RSLS ] has closed above bottom band by 41.1%. Bollinger Bands are 73.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.29 - 3.31 3.31 - 3.33
Low: 2.96 - 2.98 2.98 - 3
Close: 3.05 - 3.08 3.08 - 3.11

Company Description

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Headline News

Thu, 23 Mar 2023
ReShape Lifesciences Announces Formation of International ... - GlobeNewswire

Wed, 22 Mar 2023
Holdings of ReShape Lifesciences Inc. (RSLS) are aligned with the ... - SETE News

Tue, 21 Mar 2023
Is ReShape Lifesciences Inc (RSLS) Stock About to Get Hot Tuesday? - InvestorsObserver

Mon, 20 Mar 2023
ReShape Lifesciences Inc.'s (RSLS) Stock: A 61.03% Annual ... - The News Heater

Wed, 15 Mar 2023
ReShape Lifesciences® to Present at the Q2 Virtual Investor Summit -

Mon, 27 Feb 2023
Is ReShape Lifesciences Inc (RSLS) Stock a Smart Investment Monday? - InvestorsObserver

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 6.4 (%)
% Held by Institutions 13.2 (%)
Shares Short 19 (K)
Shares Short P.Month 2 (K)

Stock Financials

EPS -3.13
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.34
Profit Margin (%) 0
Operating Margin (%) -241.2
Return on Assets (ttm) -28.6
Return on Equity (ttm) -130
Qtrly Rev. Growth -24.5
Gross Profit (p.s.) 17.26
Sales Per Share 23.3
EBITDA (p.s.) -51.67
Qtrly Earnings Growth 0
Operating Cash Flow -23 (M)
Levered Free Cash Flow -9 (M)

Stock Valuations

PE Ratio -0.99
PEG Ratio 0
Price to Book value 1.31
Price to Sales 0.13
Price to Cash Flow -0.07

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-07-24
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.